マーケットレポート詳細

創傷ケアの世界市場:2027年に至るケア製品別、創傷タイプ別予測

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region - Global Forecast to 2027

出版元:MarketsandMarkets   出版元について
発行年:2022年6月
定価 :Single User License(1名様ライセンス)US$8,150(米国ドル)/ Multi User License(5名様)$10,150 / Corporate User License $12,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文308ページになります。
商品コード:MAM2961

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

創傷ケアの世界市場規模は2022年で208億ドル、2027年に272億ドル、市場の平均年成長率は5.4%になると当レポートは予測しています。
レポートは創傷ケアの世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(製品別市場、創傷タイプ別市場、等)を中心に構成されています。また競合状況、主要企業情報(15社)、ファイブフォース分析、市場シェア分析などの分析も加味し、創傷ケア市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆創傷ケアの世界市場予測2020-2027年

・市場規模(US$)

◆製品別、市場-2027年

<先進創傷ケア製品>
先進創傷ケアドレッシング
・フォームドレッシング
-シリコンドレッシング
-ノンシリコンドレッシング
・ハイドロコロイドドレッシング
・フィルムドレッシング
・アルギン酸ドレッシング
・ハイドロゲルドレッシング
・コラーゲンドレッシング
・ハイドロファイバードレッシング
・創傷接触層
・高吸収性ドレッシング
・その他先進創傷ケアドレッシング

創傷治療デバイス
・ポータブル及び従来型陰圧閉鎖療法デバイス(NPWT)
・創傷清拭装置/アクセサリ
・創傷アセスメント/監視デバイス

その他デバイス/アクセサリ
移植片/マトリックス
局所薬

<手術用創傷ケア製品>
縫合
ステープル
組織接着剤/シーラント及び接着剤
・フィブリンシーラント
・コラーゲンシーラント
・合成接着剤

<従来型創傷ケア製品>
医療用テープ
ドレッシング
洗浄剤
※(市場規模US$)

◆創傷タイプ別、市場-2027年

・外科及び外傷性創傷
・糖尿病性足潰瘍
・褥瘡
・静脈下腿潰瘍
・火傷/その他創傷
※(市場規模US$)

◆エンドユーザー別、市場-2027年

病院/クリニック
・入院患者
・外来患者
在宅ケア
長期ケア施設
その他エンドユーザー
※(市場規模US$)

◆主要国地域別市場-2027年

北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン、ロシア
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国、シンガポール
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19の影響
・価格分析
・特許分析
・バリューチェーン分析
・エコシステム
・ファイブフォース分析
・ケーススタディ
・市場シェア分析
・競合状況

◆創傷ケアの主要企業プロフィール動向

・3M COMPANY
・CARDINAL HEALTH
・MEDTRONIC PLC
・B. BRAUN MELSUNGEN AG
・SMITH & NEPHEW PLC
・MÖLNLYCKE HEALTH CARE AB
・PAUL HARTMANN AG
・CONVATEC GROUP
・ZIMMER BIOMET HOLDINGS INC.
・BAXTER INTERNATIONAL, INC.
・ORGANOGENESIS HOLDINGS INC.
・INTEGRA LIFESCIENCES HOLDINGS CORPORATION
・COLOPLAST A/S
・MIMEDX GROUP, INC.
・BIOVENTUS

(その他企業)
・ETHICON, INC.
・DEROYAL INDUSTRIES
・KERECIS
・ACELL
・LOHMANN & RAUSCHER GMBH & CO KG.
・MEDELA AG
・TALLEY GROUP
・WELCARE INDUSTRIES SPA
・WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
・PENSAR MEDICAL
・HAROMED BV
・DERMARITE INDUSTRIES LLC
・MEDLINE INDUSTRIS, INC.
・ADVANCIS MEDICAL LLC
・MIL LABORATORIES PVT. LTD.

(全308頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3             MARKETS COVERED
1.3.1              WOUND CARE MARKET  37
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS   38
1.6             STAKEHOLDERS
1.7             SUMMARY OF CHANGES

2      RESEARCH METHODOLOGY

2.1             RESEARCH DATA
2.2             RESEARCH APPROACH
・     ・     FIGURE 1              WOUND CARE MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1              SECONDARY DATA
2.2.1.1            KEY DATA FROM SECONDARY SOURCES
2.2.2              PRIMARY DATA
2.2.2.1            PRIMARY SOURCES
2.2.2.2            KEY DATA FROM PRIMARY SOURCES
2.2.2.3            KEY INDUSTRY INSIGHTS
2.2.2.4            BREAKDOWN OF PRIMARY INTERVIEWS
・     ・     FIGURE 2              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS
・     ・     FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
2.3             MARKET SIZE ESTIMATION
2.3.1              BOTTOM-UP APPROACH
2.3.1.1            APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・     ・     FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2            APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.3.1.3            GROWTH FORECAST
2.3.1.4            CAGR PROJECTIONS
・     ・     FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2              TOP-DOWN APPROACH   47
・     ・     FIGURE 6              WOUND CARE MARKET: TOP-DOWN APPROACH


2.4             MARKET BREAKDOWN AND DATA TRIANGULATION
・     ・     FIGURE 7              DATA TRIANGULATION METHODOLOGY
2.5             MARKET SHARE
2.6             ASSUMPTIONS FOR THE STUDY
2.7             LIMITATIONS   51
2.8             GROWTH RATE ASSUMPTIONS
2.9             RISK ASSESSMENT
2.9.1              RISK ASSESSMENT: WOUND CARE MARKET

3      EXECUTIVE SUMMARY

・     ・     FIGURE 8              WOUND CARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
・     ・     FIGURE 9              WOUND CARE MARKET, BY WOUND TYPE, 2022 VS. 2027 (USD MILLION)
・     ・     FIGURE 10            WOUND CARE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
・     ・     FIGURE 11            WOUND CARE MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4      PREMIUM INSIGHTS

4.1             WOUND CARE MARKET OVERVIEW
・     ・     FIGURE 12            GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE THE MARKET GROWTH
4.2             WOUND CARE MARKET SHARE, BY PRODUCT, 2022 VS. 2027
・     ・     FIGURE 13            THE ADVANCED WOUND CARE PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.3             WOUND CARE MARKET SHARE, BY WOUND TYPE, 2022 VS. 2027
・     ・     FIGURE 14            SURGICAL & TRAUMATIC SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4             WOUND CARE MARKET SHARE, BY END USER, 2022 VS. 2027
・     ・     FIGURE 15            THE HOSPITALS AND CLINICS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5             WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     ・     FIGURE 16            THE ASIA PACIFIC REGION IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5      MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・     ・     FIGURE 17            WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1              DRIVERS
5.2.1.1            GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES
5.2.1.1.1            GROWING GERIATRIC POPULATION
5.2.1.1.2            RISING PREVALENCE OF DIABETES
・     ・     FIGURE 18            INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2045 (MILLION CASES)
5.2.1.1.3            INCREASING NUMBER OF SURGICAL PROCEDURES WORLDWIDE
・     TABLE 1              PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES
PERFORMED IN THE US
5.2.2              RISING EXPENDITURE ON CHRONIC WOUNDS
5.2.3              INCREASING INCIDENCE OF BURN INJURIES
5.2.4              RISING CASES OF TRAUMATIC INJURIES
・     TABLE 2              PREVALENCE OF ROAD ACCIDENTS
5.2.5              TECHNOLOGICAL ADVANCEMENTS IN WOUND CARE PRODUCTS
5.2.6              RISING USE OF REGENERATIVE MEDICINE FOR WOUND MANAGEMENT
5.2.7              RESTRAINTS
5.2.7.1            HIGH COSTS OF ADVANCED WOUND CARE PRODUCTS
・     TABLE 3              AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
5.2.7.2            RISKS ASSOCIATED WITH THE USE OF ADVANCED WOUND CARE PRODUCTS
・     TABLE 4              RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
5.2.8              OPPORTUNITIES
5.2.8.1            GROWTH POTENTIAL OF EMERGING COUNTRIES
・     TABLE 5              STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC REGION
5.2.9              TRENDS
5.2.9.1            ACQUISITIONS BY LEADING COMPANIES IN THE MARKET
5.2.9.1.1            RISING FOCUS ON EXPANDING CURRENT TECHNOLOGIES AND LAUNCHING NOVEL PRODUCTS
5.2.9.1.2            SMART WOUND DRESSINGS FOR MINIMUM INVASIVENESS
5.2.9.1.3            CRAB SHELL BANDAGES
5.2.9.1.4            COLOR-CHANGING DRESSINGS
5.2.9.1.5            INTEGRATION OF NANOTECHNOLOGY IN ADVANCED WOUND CARE PRODUCTS
5.2.9.1.6            NOVEL WOUND ASSESSMENT & MEASUREMENT DEVICES
5.3             IMPACT OF COVID-19 ON THE WOUND CARE MARKET
5.4             PRICING ANALYSIS
・     TABLE 6              AVERAGE SELLING PRICE OF WOUND CARE PRODUCTS (2022)
5.5             PATENT ANALYSIS
・     ・     FIGURE 19            PATENT ANALYSIS OF THE WOUND CARE MARKET
5.5.1              LIST OF MAJOR PATENTS
5.6             VALUE CHAIN ANALYSIS
・     ・     FIGURE 20            VALUE CHAIN ANALYSIS OF THE WOUND CARE MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.7             SUPPLY CHAIN ANALYSIS
・     ・     FIGURE 21            WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
5.8             ECOSYSTEM/MARKET MAP
・     ・     FIGURE 22            WOUND CARE MARKET: ECOSYSTEM/MARKET MAP
5.8.1              WOUND CARE MARKET: ECOSYSTEM ROLE
5.9             PORTER’S FIVE FORCES ANALYSIS
・     TABLE 7              WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1              THREAT FROM NEW ENTRANTS
5.9.2              THREAT FROM SUBSTITUTES
5.9.3              BARGAINING POWER OF BUYERS
5.9.4              BARGAINING POWER OF SUPPLIERS
5.9.5              DEGREE OF COMPETITION
5.10          REGULATORY LANDSCAPE
・     TABLE 8              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 9              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 10            LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 11            REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1            NORTH AMERICA
5.10.1.1          US
5.10.1.2          CANADA
5.10.2            EUROPE
5.10.3            ASIA PACIFIC
5.10.3.1          CHINA
5.10.3.2          JAPAN
5.10.3.3          INDIA
5.10.4            LATIN AMERICA
5.10.4.1          BRAZIL
5.10.4.2          MEXICO
5.10.5            MIDDLE EAST
5.10.6            AFRICA
5.11          TRADE ANALYSIS
5.11.1            TRADE ANALYSIS FOR ADHESIVE DRESSINGS
5.11.1.1          IMPORT DATA FOR ADHESIVE DRESSINGS BY COUNTRY,
2017–2021 (USD MILLION)
5.11.1.2          EXPORT DATA FOR ADHESIVE DRESSINGS BY COUNTRY,
2017–2021 (USD MILLION)
5.12          TECHNOLOGY ANALYSIS
5.13          KEY CONFERENCES & EVENTS IN 2022–2023
・     TABLE 12            WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14          TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14.1            REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC   84
5.14.2            REVENUE SHIFT IN THE WOUND CARE MARKET
5.15          KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1            KEY STAKEHOLDERS IN THE BUYING PROCESS
・     ・     FIGURE 23            INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS
・     TABLE 13            INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS (%)
5.15.2            BUYING CRITERIA   86
・     ・     FIGURE 24            KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
・     TABLE 14            KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
5.16          CASE STUDIES
5.16.1            CASE STUDY: TIELLE ESSENTIAL SILICONE FOAM DRESSINGS USED IN A NON-HEALING DIABETIC FOOT ULCER ON THE RIGHT FOOT

6      WOUND CARE MARKET, BY PRODUCT

6.1             INTRODUCTION
・     TABLE 15            WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.1.1              PRIMARY NOTES
6.1.1.1            KEY INDUSTRY INSIGHTS
6.2             ADVANCED WOUND CARE PRODUCTS
・     TABLE 16            ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 17            ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION)
6.2.1              ADVANCED WOUND CARE DRESSINGS
・     TABLE 18            ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 19            ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION)
6.2.1.1            FOAM DRESSINGS
・     TABLE 20            KEY PRODUCTS IN THE FOAM DRESSINGS MARKET
・     TABLE 21            FOAM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 22            FOAM DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1.1            SILICONE DRESSINGS
6.2.1.1.1.1         SILICONE DRESSINGS HELP EXPEDITE WOUND CLOSURE AND REDUCE THE RISK OF MACERATION – A KEY FACTOR DRIVING THE MARKET GROWTH
・     TABLE 23            SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1.2            NON-SILICONE DRESSINGS
6.2.1.1.2.1         NON-SILICONE DRESSINGS ARE EFFECTIVE IN SCAR REMOVAL AND WOUND HEALING
・     TABLE 24            NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2            HYDROCOLLOID DRESSINGS
6.2.1.2.1            HYDROCOLLOID DRESSINGS ARE COST-EFFECTIVE AND PROMOTE A MOIST ENVIRONMENT WHICH IS REQUIRED FOR OPTIMAL HEALING
・     TABLE 25            KEY PRODUCTS IN THE HYDROCOLLOID DRESSINGS MARKET
・     TABLE 26            HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.3            FILM DRESSINGS
6.2.1.3.1            THE NON-ABSORBABLE NATURE OF FILM DRESSINGS ENSURES STRONG ADOPTION
・     TABLE 27            FILM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.4            ALGINATE DRESSINGS
6.2.1.4.1            ALGINATE DRESSINGS ARE WELL SUITED FOR DIABETIC & FOOT ULCERS
・     TABLE 28            ALGINATE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.5            HYDROGEL DRESSINGS
6.2.1.5.1            HYDROGEL DRESSINGS ARE AVAILABLE IN SEVERAL FORMS FOR EFFECTIVE USE

・     TABLE 29            HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.6            COLLAGEN DRESSINGS
6.2.1.6.1            A FAVORABLE REIMBURSEMENT SCENARIO FOR COLLAGEN DRESSINGS TO SUPPORT THE MARKET GROWTH
・     TABLE 30            COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.7            HYDROFIBER DRESSINGS
6.2.1.7.1            HYDROFIBER DRESSINGS COMBINE THE PROPERTIES OF HYDROCOLLOIDS AND COLLAGEN
・     TABLE 31            HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.8            WOUND CONTACT LAYERS
6.2.1.8.1            WOUND CONTACT LAYERS PROTECT WOUND BEDS FROM BACTERIAL & FUNGAL GROWTH
・     TABLE 32            WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.9            SUPERABSORBENT DRESSINGS
6.2.1.9.1            SUPERABSORBENT DRESSINGS ARE DESIGNED FOR HIGHLY EXUDING WOUNDS
・     TABLE 33            SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.10          OTHER ADVANCED WOUND CARE DRESSINGS
・     TABLE 34            OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 35            ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 36            NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 37            ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION)
6.2.2              WOUND THERAPY DEVICES
・     TABLE 38            WOUND THERAPY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 39            WOUND THERAPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.2.1            POR・     TABLE & CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
6.2.2.1.1            GROWING ADOPTION OF SINGLE-USE NPWT DEVICES IN HOMECARE TO DRIVE THE MARKET GROWTH
・     TABLE 40            POR・     TABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.2            DEBRIDEMENT DEVICES & ACCESSORIES
6.2.2.2.1            DEVELOPMENT OF NOVEL TECHNOLOGIES TO SUPPORT THE GROWTH OF THIS SEGMENT
・     TABLE 41            DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.3            WOUND ASSESSMENT & MONITORING DEVICES
6.2.2.3.1            POTENTIAL COST-REDUCING CAPABILITIES OF WOUND ASSESSMENT & MONITORING DEVICES TO BOOST ITS ADOPTION
・     TABLE 42            WOUND ASSESSMENT & MONITORING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3              OTHER DEVICES & ACCESSORIES
・     TABLE 43            OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.4              GRAFTS & MATRICES
6.2.4.1            GRAFTS & MATRICES PROMOTE HEALING & WOUND CLOSURE
・     TABLE 44            KEY PRODUCTS IN THE GRAFTS & MATRICES MARKET
・     TABLE 45            GRAFTS & MATRICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5              TOPICAL AGENTS
6.2.5.1            COST-EFFECTIVENESS & EASE-OF-USE IN HOME CARE SETTINGS TO DRIVE THE GROWTH OF THIS SEGMENT
・     TABLE 46            TOPICAL AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3             SURGICAL WOUND CARE PRODUCTS
・     TABLE 47            SURGICAL CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 48            SURGICAL CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1              SUTURES
6.3.1.1            INCREASING NUMBER OF SURGICAL PROCEDURES AND THE HIGH TENSILE STRENGTH AFFORDED BY SUTURES DRIVE THE MARKET GROWTH
・     TABLE 49            SUTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2              STAPLERS
6.3.2.1            STAPLERS ARE CONSIDERED TO BE MORE ACCURATE THAN SUTURING AND LESS LIKELY TO ALLOW LEAKAGE; A KEY FACTOR DRIVING ADOPTION   123
・     TABLE 50            STAPLERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3              TISSUE ADHESIVES, SEALANTS, AND GLUES
・     TABLE 51            TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 52            TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION,
2020–2027 (USD MILLION)
6.3.3.1            FIBRIN-BASED SEALANTS
6.3.3.1.1            FIBRIN-BASED SEALANTS PROVIDE BETTER RESULTS THAN SUTURES, THUS DRIVING THE PRODUCT DEMAND
・     TABLE 53            FIBRIN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.3.2            COLLAGEN-BASED SEALANTS
6.3.3.2.1            COLLAGEN-BASED SEALANTS ARE USED IN SURGICAL PROCEDURES AS AN ADJUNCTIVE TO HEMOSTATIC AGENTS
・     TABLE 54            COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.3.3            SYNTHETIC ADHESIVES
6.3.3.3.1            SYNTHETIC ADHESIVES HAVE ADDITIONAL SEALING PROPERTIES THAN TRADITIONAL STAPLES; A KEY FACTOR DRIVING THE SEGMENT GROWTH
・     TABLE 55            SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4             TRADITIONAL WOUND CARE PRODUCTS
・     TABLE 56            TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 57            TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION)
6.4.1              MEDICAL TAPES
6.4.1.1            LATEX-FREE TAPES ARE GENTLE TO THE SKIN AND HYPOALLERGENIC FOR SENSITIVE PATIENTS
・     TABLE 58            MEDICAL TAPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.2              DRESSINGS
6.4.2.1            PRESENCE OF A LARGE PATIENT POPULATION FOR PRESSURE ULCERS HAS ENSURED A SUSTAINED DEMAND FOR THESE PRODUCTS
・     TABLE 59            DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.3              CLEANSING AGENTS   134
6.4.3.1            HIGH RISK OF HAIS FROM OPEN WOUNDS TO DRIVE THE MARKET GROWTH
・     TABLE 60            TYPES OF CLEANSING AGENTS
・     TABLE 61            CLEANSING AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7      WOUND CARE MARKET, BY WOUND TYPE   136

7.1             INTRODUCTION
・     TABLE 62            WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
7.2             SURGICAL & TRAUMATIC WOUNDS
7.2.1              THE RISING VOLUME OF SURGICAL PROCEDURES DRIVES THE GROWTH OF THIS SEGMENT
・     TABLE 63            WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,
BY COUNTRY, 2020–2027 (USD MILLION)
7.3             DIABETIC FOOT ULCERS
7.3.1              INCREASING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
・     TABLE 64            TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN
2021 (20-79 AGE GROUP)
・     TABLE 65            WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY,
2020–2027 (USD MILLION)
7.4             PRESSURE ULCERS
7.4.1              GROWING GERIATRIC POPULATION TO DRIVE THE GROWTH OF THIS SEGMENT
・     TABLE 66            WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY,
2020–2027 (USD MILLION)
7.5             VENOUS LEG ULCERS
7.5.1              RISING PREVALENCE OF OBESITY TO DRIVE THE GROWTH OF THIS SEGMENT
・     TABLE 67            WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY,
2020–2027 (USD MILLION)

7.6             BURNS AND OTHER WOUNDS
7.6.1              HIGH INCIDENCE OF BURN INJURIES TO DRIVE THE MARKET GROWTH
・     TABLE 68            WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY,
2020–2027 (USD MILLION)

8      WOUND CARE MARKET, BY END USER

8.1             INTRODUCTION
・     TABLE 69            WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2             HOSPITALS AND CLINICS
・     TABLE 70            TOTAL NUMBER OF HOSPITALS, BY COUNTRY (IN 2019)
・     TABLE 71            WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 72            WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY TYPE,
2020–2027 (USD MILLION)
8.2.1              INPATIENT SETTINGS
8.2.1.1            INCREASING HOSPITAL ADMISSIONS DUE TO HAIS TO DRIVE THE GROWTH OF THIS SEGMENT
・     TABLE 73            WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION)
8.2.2              OUTPATIENT SETTINGS
8.2.2.1            RISING COSTS OF INPATIENT FACILITIES DRIVE THE DEMAND FOR OUTPATIENT CARE SETTINGS
・     TABLE 74            WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION)
8.3             HOME CARE SETTINGS
8.3.1              LOW COSTS AND CONVENIENCE TO DRIVE THE GROWTH OF
THIS END-USER SEGMENT
・     TABLE 75            WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION)
8.4             LONG-TERM CARE FACILITIES
8.4.1              GROWTH IN THE GERIATRIC & VULNERABLE POPULATIONS DRIVES THE DEMAND FOR BETTER LONG-TERM CARE   153
・     TABLE 76            WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5             OTHER END USERS
・     TABLE 77            WOUND CARE MARKET FOR OTHER END-USERS, BY COUNTRY,
2020–2027 (USD MILLION)

9      WOUND CARE MARKET, BY REGION

9.1             INTRODUCTIONS
・     TABLE 78            WOUND CARE MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2             NORTH AMERICA
・     ・     FIGURE 25            NORTH AMERICA: WOUND CARE MARKET SNAPSHOT
・     TABLE 79            NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 80            NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 81            NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 82            NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)  160
・     TABLE 83            NORTH AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 84            NORTH AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
・     TABLE 85            NORTH AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 86            NORTH AMERICA: WOUND CARE MARKET; BY TISSUES ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
・     TABLE 87            NORTH AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  162
・     TABLE 88            NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 89            NORTH AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.2.1              US
9.2.1.1            RISING INCIDENCE OF CHRONIC DISEASES AND DIABETES TO
DRIVE THE MARKET GROWTH
・     TABLE 90            US: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 91            US: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2              CANADA
9.2.2.1            HIGH PREVALENCE OF HAIS DRIVES THE MARKET GROWTH FOR WOUND CARE MANAGEMENT IN CANADA
・     TABLE 92            INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029
・     TABLE 93            CANADA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 94            CANADA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3             EUROPE

・     TABLE 95            EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
・     TABLE 96            PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045
・     TABLE 97            EUROPE: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 98            EUROPE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 99            EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 100          EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 101          EUROPE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 102          EUROPE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION)
・     TABLE 103          EUROPE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 104          EUROPE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)  171
・     TABLE 105          EUROPE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  171
・     TABLE 106          EUROPE: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 107          EUROPE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1              GERMANY
9.3.1.1            THE LARGE DIABETIC POPULATION IN GERMANY HAS SUPPORTED PRODUCT DEVELOPMENT & COMMERCIALIZATION FOR THE WOUND CARE MARKET
・     TABLE 108          GERMANY: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 109          GERMANY: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.2              FRANCE
9.3.2.1            THE RISING SENIOR POPULATION DRIVES THE MARKET GROWTH IN FRANCE
・     TABLE 110          FRANCE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 111          FRANCE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3              UK
9.3.3.1            RISING INCIDENCE OF CHRONIC WOUNDS TO PROPEL MARKET GROWTH IN THE UK
・     TABLE 112          UK: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 113          UK: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4              ITALY
9.3.4.1            GROWTH IN THIS MARKET IS DRIVEN BY IMPROVING QUALITY & ACCESSIBILITY TO MEDICAL CARE AND PRODUCTS
・     TABLE 114          ITALY: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 115          ITALY: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5              SPAIN
9.3.5.1            INCREASING LIFE EXPECTANCIES AND THE GROWING GERIATRIC POPULATION TO ENSURE THE MARKET GROWTH IN SPAIN
・     TABLE 116          SPAIN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 117          SPAIN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6              RUSSIA
9.3.6.1            GOVERNMENT FOCUS ON INCREASING DIABETES AWARENESS TO FAVOR THE MARKET GROWTH
・     TABLE 118          RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 119          RUSSIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.7              REST OF EUROPE
・     TABLE 120          ROE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 121          ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE
PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 122          ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 123          ROE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 124          ROE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION)
・     TABLE 125          ROE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 126          ROE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)  183
・     TABLE 127          ROE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 128          ROE: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
・     TABLE 129          ROE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4             ASIA PACIFIC
・     ・     FIGURE 26            ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT
・     TABLE 130          ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 131          ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 132          ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 133          ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)  187
・     TABLE 134          ASIA PACIFIC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 135          ASIA PACIFIC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION)
・     TABLE 136          ASIA PACIFIC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 137          ASIA PACIFIC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
・     TABLE 138          ASIA PACIFIC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  189
・     TABLE 139          ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 140          ASIA PACIFIC: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.1              CHINA
9.4.1.1            INCREASING INCIDENCE OF DFUS TO SUPPORT THE MARKET GROWTH IN CHINA
・     TABLE 141          CHINA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 142          CHINA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2              JAPAN
9.4.2.1            IMPLEMENTATIONS OF REGULATIONS IN JAPAN HAVE RESULTED IN A FAVORABLE ENVIRONMENT FOR WOUND CARE DEVICES
・     TABLE 143          JAPAN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 144          JAPAN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3              INDIA
9.4.3.1            GROWING MEDICAL TOURISM IN INDIA TO SUPPORT THE MARKET GROWTH FOR WOUND CARE MANAGEMENT
・     TABLE 145          INDIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 146          INDIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4              AUSTRALIA
9.4.4.1            INCREASING INITIATIVES TO SPREAD AWARENESS ON EFFECTIVE WOUND CARE TO SUPPORT THE MARKET GROWTH
・     TABLE 147          AUSTRALIA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 148          AUSTRALIA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.5              SOUTH KOREA
9.4.5.1            LOCAL MANUFACTURERS IN SOUTH KOREA ARE PARTNERING WITH RESEARCH ORGANIZATIONS FOR ADVANCED WOUND CARE PRODUCTS; A KEY GROWTH DRIVER
・     TABLE 149          SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 150          SOUTH KOREA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.6              SINGAPORE
9.4.6.1            THE GROWING PREVALENCE OF DIABETES DRIVES THE MARKET GROWTH IN SINGAPORE
・     TABLE 151          SINGAPORE: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 152          SINGAPORE: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.7              REST OF ASIA PACIFIC
・     TABLE 153          ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 154          ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 155          ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 156          ROAPAC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 157          ROAPAC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION)
・     TABLE 158          ROAPAC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 159          ROAPAC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)  201
・     TABLE 160          ROAPAC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  201
・     TABLE 161          ROAPAC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 162          ROAPAC: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5             LATIN AMERICA
・     TABLE 163          LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 164          LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 165          LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 166          LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)  204
・     TABLE 167          LATIN AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 168          LATIN AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
・     TABLE 169          LATIN AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 170          LATIN AMERICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
・     TABLE 171          LATIN AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  206
・     TABLE 172          LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 173          LATIN AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)
9.5.1              BRAZIL
9.5.1.1            BRAZIL IS THE LARGEST HEALTHCARE MARKET IN LATIN AMERICA
・     TABLE 174          BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 175          BRAZIL: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2              MEXICO
9.5.2.1            DIABETES IS THE SECOND-HIGHEST CAUSE OF MORTALITY IN MEXICO
・     TABLE 176          MEXICO: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 177          MEXICO: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3              REST OF LATIN AMERICA
・     TABLE 178          ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 179          ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 180          ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 181          ROLATAM: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION)
・     TABLE 182          ROLATAM: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION)
・     TABLE 183          ROLATAM: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 184          ROLATAM: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)  212
・     TABLE 185          ROLATAM: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)  212
・     TABLE 186          ROLATAM: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 187          ROLATAM: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)

9.6             MIDDLE EAST & AFRICA
9.6.1              RISING PREVALENCE OF DIABETES IN THE REGION TO SUPPORT
THE MARKET GROWTH
・     TABLE 188          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 189          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 190          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 191          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
・     TABLE 192          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
・     TABLE 193          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 194          MIDDLE EAST & AFRICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
・     TABLE 195          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY TRADITIONAL
WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
・     TABLE 196          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION)
・     TABLE 197          MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION)

10   COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1            OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE WOUND CARE MARKET
・     TABLE 198          OVERVIEW OF STRATEGIES DEPLOYED BY KEY WOUND CARE MANUFACTURING COMPANIES
10.3          REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・     ・     FIGURE 27            REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
10.4          MARKET SHARE ANALYSIS
10.4.1            WOUND CARE MARKET
・     ・     FIGURE 28            WOUND CARE MARKET SHARE BY KEY PLAYER (2021)
・     TABLE 199          WOUND CARE MARKET: DEGREE OF COMPETITION
10.4.1.1          ADVANCED WOUND CARE
・     ・     FIGURE 29            GLOBAL WOUND CARE MARKET SHARE FOR ADVANCED WOUND CARE
BY KEY PLAYERS (2021)

10.4.1.2          NEGATIVE PRESSURE WOUND THERAPY (NPWT)
・     ・     FIGURE 30            GLOBAL WOUND CARE MARKET SHARE FOR NPWT BY KEY PLAYER (2021)
10.4.1.3          ADVANCED WOUND DRESSINGS
・     ・     FIGURE 31            GLOBAL WOUND CARE MARKET RANKING FOR ADVANCED WOUND DRESSINGS, BY KEY PLAYER, 2021
10.4.1.4          SURGICAL SUTURES
・     ・     FIGURE 32            GLOBAL WOUND CARE MARKET RANKING FOR SURGICAL SUTURES, BY KEY PLAYER, 2021
10.4.1.5          DEBRIDEMENT DEVICES
・     ・     FIGURE 33            GLOBAL WOUND CARE MARKET RANKING FOR DEBRIDEMENT DEVICES,
BY KEY PLAYER, 2021
10.4.1.6          TRADITIONAL AND SURGICAL WOUND CARE PRODUCT MARKETS
・     TABLE 200          GLOBAL WOUND CARE MARKET RANKING FOR TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS, BY KEY PLAYER, 2021
10.5          COMPANY EVALUATION QUADRANT
10.5.1            LIST OF EVALUATED VENDORS
10.5.2            STARS
10.5.3            EMERGING LEADERS
10.5.4            PERVASIVE PLAYERS
10.5.5            PARTICIPANTS
・     ・     FIGURE 34            WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6          COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1            PROGRESSIVE COMPANIES
10.6.2            STARTING BLOCKS   228
10.6.3            RESPONSIVE COMPANIES
10.6.4            DYNAMIC COMPANIES   228
・     ・     FIGURE 35            WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7          COMPETITIVE BENCHMARKING
10.7.1            PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
・     ・     FIGURE 36            PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
・     TABLE 201          WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
・     TABLE 202          COMPANY PRODUCT & SERVICE FOOTPRINT
・     TABLE 203          COMPANY REGIONAL FOOTPRINT
・     TABLE 204          WOUND CARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8          COMPETITIVE SCENARIO   232
10.8.1            PRODUCT LAUNCHES
・     TABLE 205          KEY PRODUCT LAUNCHES &
10.8.2            DEALS
・     TABLE 206          KEY DEALS

11   COMPANY PROFILES

11.1          KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
11.1.1            3M COMPANY
・     TABLE 207          3M COMPANY: BUSINESS OVERVIEW
・     ・     FIGURE 37            3M COMPANY: BUSSINESS OVERVIEW (2021)
11.1.2            CARDINAL HEALTH   240
・     TABLE 208          CARDINAL HEALTH.: BUSINESS OVERVIEW
・     ・     FIGURE 38            CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.3            MEDTRONIC PLC
・     TABLE 209          MEDTRONIC PLC: BUSINESS OVERVIEW
・     ・     FIGURE 39            MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4            B. BRAUN MELSUNGEN AG
・     TABLE 210          B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
・     ・     FIGURE 40            B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021)
11.1.5            SMITH & NEPHEW PLC
・     TABLE 211          SMITH & NEPHEW PLC: BUSINESS OVERVIEW
・     ・     FIGURE 41            SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
11.1.6            MÖLNLYCKE HEALTH CARE AB
・     TABLE 212          MÖLNLYCKE HEALTH CARE AB: BUSINESS OVERVIEW
・     ・     FIGURE 42            MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2021)
11.1.7            PAUL HARTMANN AG   265
・     TABLE 213          PAUL HARTMANN AG: BUSINESS OVERVIEW
・     ・     FIGURE 43            PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
11.1.8            CONVATEC GROUP
・     TABLE 214          CONVATEC GROUP: BUSINESS OVERVIEW
・     ・     FIGURE 44            CONVATEC GROUP: COMPANY SNAPSHOT (2021)
11.1.9            ZIMMER BIOMET HOLDINGS INC.
・     TABLE 215          ZIMMER BIOMET HOLDINGS INC.: BUSINESS OVERVIEW
・     ・     FIGURE 45            ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.10         BAXTER INTERNATIONAL, INC.
・     TABLE 216          BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
・     ・     FIGURE 46            BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
11.1.11         ORGANOGENESIS HOLDINGS INC.
・     TABLE 217          ORGANOGENESIS HOLDINGS INC.: BUSINESS OVERVIEW
・     ・     FIGURE 47            ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.12         INTEGRA LIFESCIENCES HOLDINGS CORPORATION
・     TABLE 218          INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
・     ・     FIGURE 48            INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2021)
11.1.13         COLOPLAST A/S
・     TABLE 219          COLOPLAST A/S: BUSINESS OVERVIEW
・     ・     FIGURE 49            COLOPLAST A/S: COMPANY SNAPSHOT (2021)
11.1.14         MIMEDX GROUP, INC.
・     TABLE 220          MIMEDX GROUP, INC.: BUSINESS OVERVIEW
・     ・     FIGURE 50            MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2021)
11.1.15         BIOVENTUS
・     TABLE 221          BIOVENTUS: BUSINESS OVERVIEW
・     ・     FIGURE 51            BIOVENTUS: COMPANY SNAPSHOT (2021)
11.2          OTHER PLAYERS
11.2.1            ETHICON, INC.
・     TABLE 222          ETHICON, INC.: COMPANY OVERVIEW
11.2.2            DEROYAL INDUSTRIES
・     TABLE 223          DEROYAL INDUSTRIES: COMPANY OVERVIEW
11.2.3            KERECIS
・     TABLE 224          KERECIS: COMPANY OVERVIEW
11.2.4            ACELL
・     TABLE 225          ACELL: COMPANY OVERVIEW
11.2.5            LOHMANN & RAUSCHER GMBH & CO KG.
・     TABLE 226          LOHMANN & RAUSCHER GMBH & CO KG.: COMPANY OVERVIEW
11.2.6            MEDELA AG
・     TABLE 227          MEDELA AG: COMPANY OVERVIEW
11.2.7            TALLEY GROUP
・     TABLE 228          TALLEY GROUP: COMPANY OVERVIEW
11.2.8            WELCARE INDUSTRIES SPA
・     TABLE 229          ELCARE INDUSTRIES SPA: COMPANY OVERVIEW
11.2.9            WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
・     TABLE 230          WUHAN VSD SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
11.2.10         PENSAR MEDICAL
・     TABLE 231          PENSAR MEDICAL: COMPANY OVERVIEW
11.2.11         HAROMED BV
・     TABLE 232          HAROMED BV: COMPANY OVERVIEW
11.2.12         DERMARITE INDUSTRIES LLC
・     TABLE 233          DERMARITE INDUSTRIES LLC: COMPANY OVERVIEW
11.2.13         MEDLINE INDUSTRIS, INC.
・     TABLE 234          MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
11.2.14         ADVANCIS MEDICAL LLC
・     TABLE 235          ADVANCIS MEDICAL LLC: COMPANY OVERVIEW
11.2.15         MIL LABORATORIES PVT. LTD.
・     TABLE 236          MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12   APPENDIX

12.1          DISCUSSION GUIDE
12.2          KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3          AVAILABLE CUSTOMIZATIONS
12.4          RELATED REPORTS
12.5          AUTHOR DETAILS


△ 一番上に戻る